David Rendall serves as Executive at PURE BIOSCIENCE, INC., where they oversee executive responsibilities. Since joining the company, David Rendall has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 15, 2022 involved receiving (via award) 325,000 shares valued at $48.8K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jul 15, 2022 | PURE | $48.8K | Award | 325,000 | $0.15 | Discretionary |
David Rendall currently holds 402,371 shares of PURE BIOSCIENCE, INC. (PURE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Rendall has been a net neutral trader of PURE stock. They have purchased $0 and sold $0 worth of shares.
David Rendall's most recent insider trade was on Jul 15, 2022, when they sold 325,000 shares at $0.15 per share.
Get notified when new Form 4 filings are submitted